Physician
Retina & Vitreous Consultants of Wi, LTD.
Retina & Vitreous Consultants of Wi, LTD. was paid $3.78M by Medicaid between Jan 2018 and Dec 2024, across 23 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 64% of everything it billed.
33Billing provider infoRETINA & VITREOUS CONSULTANTS OF WI, LTD.
MILWAUKEE, WI 53226
MILWAUKEE, WI 53226
33aNPI1114044435assigned 03/23/2007
33bProvider typeOphthalmology Physician
28Total paid$3.78M
24GClaims44,423
24DCodes billed23
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Wisconsin
Rank by total paid#1 of 43
Median peer was paid$4K
This provider vs. median867×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,392 | $406K | |
| 2019 | 5,261 | $461K | |
| 2020 | 4,988 | $491K | |
| 2021 | 7,574 | $773K | |
| 2022 | 6,008 | $629K | |
| 2023 | 8,294 | $577K | |
| 2024incomplete | 6,906 | $444K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 64% | 3,593 | 2,430 | $2.41M |
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 12,791 | 9,547 | $789K |
| J9035 | Injection, bevacizumab, 10 mg | 6.7% | 7,904 | 5,131 | $255K |
| 92134 | 4.2% | 12,882 | 10,106 | $158K | |
| 67228 | 1.5% | 176 | 132 | $55K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.2% | 3,200 | 2,507 | $45K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 835 | 597 | $21K |
| 92235 | <1% | 384 | 330 | $19K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 291 | 228 | $9K |
| 92250 | <1% | 710 | 590 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 200 | 158 | $7K |
| 2024F | <1% | 89 | 81 | $130.00 |
11 more codes
| 2026F | <1% | 89 | $130.00 | |
| 2022F | <1% | 89 | $130.00 | |
| 1036F | <1% | 197 | $0.07 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 88 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 197 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 75 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 278 | $0.00 |
| 2021F | 0% | 111 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 124 | $0.00 |
| 5010F | 0% | 88 | $0.00 | |
| 4040F | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAJA, SHARATH (PRESIDENT)